Know Cancer

or
forgot password

Value of 18F-Fluordeoxyglucose Positron Emission Tomography/ Computed Tomography and Molecular Tumor Characterisation in Preoperative Staging og Postoperative Control of Colon Cancer


N/A
18 Years
N/A
Open (Enrolling)
Both
Colon Cancer

Thank you

Trial Information

Value of 18F-Fluordeoxyglucose Positron Emission Tomography/ Computed Tomography and Molecular Tumor Characterisation in Preoperative Staging og Postoperative Control of Colon Cancer


Inclusion Criteria:



- clinical or histological diagnosis of malignant clonic neoplasm (distance of more
than 15 cm from anal ring)

- 18 years of age or older

- written informed consent

Exclusion Criteria:

- diabetes

- known malignant disease other than colon cancer

- known metastatic disease

- impairment of renal function

- allergy to CT contrast agents

- body weight of more than 150 kg

- claustrophobia

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

time to recurrence

Principal Investigator

Bodil E Engelmann, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Naestved Hospital

Authority:

Denmark: The Danish National Committee on Biomedical Research Ethics

Study ID:

SJ-82

NCT ID:

NCT01636674

Start Date:

July 2009

Completion Date:

March 2013

Related Keywords:

  • Colon Cancer
  • positron emission tomography
  • computed tomography
  • fluordeoxyglucose
  • colon cancer
  • cancer
  • staging
  • imaging
  • Colonic Neoplasms

Name

Location